Showing results (2081-2090 of 3,173) with videos related to

Sort By:
Pageof 318
Journal of Addiction Research & Therapy|November 26, 2013
Subjective Effects of Thiopental in Young Adults with and without a Family History of AlcoholismIsmene L Petrakis, Karin Kerfoot, Brian Pittman, et al.
Biochimica Et Biophysica Acta. General Subjects|November 9, 2020
Proteomic identification of tumor- and metastasis-associated galectin-1 in claudin-low breast cancerKassondra Balestrieri, Kimberly Kew, Moses McDaniel, et al.
Clinical Neurology and Neurosurgery|September 3, 2020
Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalizationDavid Chachkhiani, Michael Y Soliman, Delphi Barua, et al.
Advances in Orthopedics|March 15, 2018
Posttraumatic Spinal Cord Injury without Radiographic AbnormalityKivanc Atesok, Nobuhiro Tanaka, Andrew O'Brien, et al.
Data in Brief|March 10, 2021
Neurological complications of COVID19 during March 2020 at LCMC health university medical center: DatasetDavid Chachkhiani, Michael Y Soliman, Delphi Barua, et al.
Journal of Clinical Microbiology|September 1, 1978
Detection of Legionnaires disease bacteria by direct immunofluorescent stainingW B Cherry, B Pittman, P P Harris, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 17, 2004
Systemic responses to prolonged hemorrhagic hypotensionLuciana N Torres, Ivo P Torres Filho, R Wayne Barbee, et al.
Headache|September 18, 2018
Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster HeadacheEmmanuelle A D Schindler, Douglas A Wright, Marsha J Weil, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2022
Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new PseudomonasJessica E Pittman, Michelle S Skalland, Scott D Sagel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2009
A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancerS Sukumaran, K B Pittman, W K Patterson, et al.
Pageof 318